Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George A Karpouzas

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
RMD Open|July 19, 2018
Latent profile analysis approach to the relationship between patient and physician global assessments of rheumatoid arthritis activityGeorge A Karpouzas, Vibeke Strand, Sarah R Ormseth
Rheumatology and Therapy|August 18, 2017
Identification and Treatment Optimization of Comorbid Depression in Rheumatoid ArthritisMellissa H Withers, Louella T Gonzalez, George A Karpouzas
Rheumatology (Oxford, England)|August 10, 2021
The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritisGeorge A Karpouzas, Sarah R Ormseth, Elizabeth Hernandez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2019
Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid ArthritisGeorge A Karpouzas, Sarah R Ormseth, Elizabeth Hernandez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 23, 2020
Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk LesionsGeorge A Karpouzas, Sarah R Ormseth, Elizabeth Hernandez, et al.
Best Practice & Research. Clinical Rheumatology|June 11, 2023
Cardiovascular risk in vasculitisDurga Prasanna Misra, Aman Sharma, George A Karpouzas, et al.
Rheumatology (Oxford, England)|March 20, 2018
High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritisGeorge A Karpouzas, Joel Estis, Panteha Rezaeian, et al.
Arthritis Care & Research|September 5, 2014
Perspectives of vulnerable U.S Hispanics with rheumatoid arthritis on depression: awareness, barriers to disclosure, and treatment optionsMellissa Withers, Rosalinda Moran, Perry Nicassio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2021
Epicardial Adipose Tissue Volume As a Marker of Subclinical Coronary Atherosclerosis in Rheumatoid ArthritisGeorge A Karpouzas, Panteha Rezaeian, Sarah R Ormseth, et al.
Journal of Autoimmunity|April 2, 2022
Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritisGeorge A Karpouzas, Sarah R Ormseth, Nicoletta Ronda, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
RMD Open|July 19, 2018
Latent profile analysis approach to the relationship between patient and physician global assessments of rheumatoid arthritis activityGeorge A Karpouzas, Vibeke Strand, Sarah R Ormseth
Rheumatology and Therapy|August 18, 2017
Identification and Treatment Optimization of Comorbid Depression in Rheumatoid ArthritisMellissa H Withers, Louella T Gonzalez, George A Karpouzas
Rheumatology (Oxford, England)|August 10, 2021
The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritisGeorge A Karpouzas, Sarah R Ormseth, Elizabeth Hernandez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2019
Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid ArthritisGeorge A Karpouzas, Sarah R Ormseth, Elizabeth Hernandez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 23, 2020
Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk LesionsGeorge A Karpouzas, Sarah R Ormseth, Elizabeth Hernandez, et al.
Best Practice & Research. Clinical Rheumatology|June 11, 2023
Cardiovascular risk in vasculitisDurga Prasanna Misra, Aman Sharma, George A Karpouzas, et al.
Rheumatology (Oxford, England)|March 20, 2018
High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritisGeorge A Karpouzas, Joel Estis, Panteha Rezaeian, et al.
Arthritis Care & Research|September 5, 2014
Perspectives of vulnerable U.S Hispanics with rheumatoid arthritis on depression: awareness, barriers to disclosure, and treatment optionsMellissa Withers, Rosalinda Moran, Perry Nicassio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2021
Epicardial Adipose Tissue Volume As a Marker of Subclinical Coronary Atherosclerosis in Rheumatoid ArthritisGeorge A Karpouzas, Panteha Rezaeian, Sarah R Ormseth, et al.
Journal of Autoimmunity|April 2, 2022
Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritisGeorge A Karpouzas, Sarah R Ormseth, Nicoletta Ronda, et al.
Pageof 4